VANCOUVER, Washington, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...
CytoDyn (CYDY) announced positive results from its preclinical studies with SMC Laboratories, SMC. The three studies demonstrated statistically ...
philstar.com on MSN1d
SMC’s eastern skyway to cost an additional P11 billionTollway builder San Miguel Corp. will spend nearly P11 billion more to construct the new expressway that runs through the ...
The students of Olympic High School are setting a precedent for their peers in Santa Monica-Malibu Unified School District, letting them know that they can take on the challenge of college courses. At ...
Social Marketing Company (SMC), a not-for-profit organisation, has completed 50 years of remarkable operations in the health ...
SMC Enterprise stands out as a unique entity, demonstrating that profitability can be achieved while maintaining strict compliance and delivering top-quality products. We have reached an annual ...
Anyone of over 30 years of age might recall radio advertisements aired during their childhood and adolescence on ...
Steel manufacturer SMC Trading Investment JSC, with 37 years of development, faces the risk of compulsory delisting due to three consecutive years of losses with nearly VND1.3 trillion ($51.4 million) ...
Santa Monica College has unveiled an ambitious plan to remake its Pico Blvd. campus. This month, SMC released its intention to develop a new master plan for its Main Campus, which serves over 30,000 ...
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback